Review
Open access
Aug 2026
The evolution of iPSC-based cell therapy across autologous and allogeneic pathways.
This review traces key field milestones and analyzes prospects and hurdles for next-generation iPSC therapies as autologous and allogeneic iPSC therapies complement each other for distinct clinical demands.
Anmin Wang, Yunpei Zhang, Hongkui Deng et al.
· Cell Reports Medicine · 0 citations